Download PDF
1 / Pages

Other users also viewed these articles

A phase 2, double-blind, placebo-controlled trial of a valproate/lithium combination in ALS patients M.-C. Boll; M. Alcaraz-Zubeldia; C. Rios; D. González-Esquivel; S. Montes;
10.1016/j.nrleng.2022.07.003
Analysis of the diagnostic pathway and delay in patients with amyotrophic lateral sclerosis in the Valencian Community J.F. Vázquez-Costa; M. Martínez-Molina; M. Fernández-Polo; V. Fornés-Ferrer; M. Frasquet-Carrera; T. Sevilla-Mantecón;
Neurologia. 2021;36:504-13
Design and validation of a questionnaire for monitoring neurological dysphagia and respiratory deterioration in patients with amyotrophic lateral sclerosis (DEREDELA) S. Bermudo Fuenmayor; P.J. Serrano Castro; P. Quiroga Subirana; S. López Palmero; M.M. Requena Mullor; T. Parrón Carreño;
Neurologia. 2024;39:666-74